Produce personalized formulas at scale
Individualized batches produced through a modular platform built for personalization.
Manufacturing Platform
Precision Manufacturing for Personalized Infant Nutrition
Auralis has developed a proprietary small-batch manufacturing platform — a core intellectual property asset designed to produce individualized infant formulas at industrial scale while maintaining pharmaceutical-grade quality standards.
A Modular, Flexible Production System
Built for personalized formula at scale.
Strict batch-level quality control
Each batch undergoes comprehensive testing before release to ensure consistency and safety.
Adapt to changing baby needs
Formula composition evolves as the infant grows, supported by responsive production scheduling.
Ensure freshness & consistency
Fresh production every two months ensures formulation is aligned with current biological needs.
Quality, Safety, and Compliance
Clinical-grade standards at every step.
GMP-Certified Facilities
All production occurs within facilities that meet or exceed Good Manufacturing Practice standards, ensuring consistent quality and safety.
Clinical-Grade Ingredients
Every ingredient used in Auralis formulations is clinically established, sourced from validated suppliers, and meets the highest safety standards for infant nutrition.
Full Traceability
From raw ingredient to finished product, every step in the manufacturing process is documented, tracked, and auditable.
Regulatory Alignment
Auralis manufacturing protocols are designed in reference to both FDA and EU infant nutrition standards, with ongoing alignment as regulatory frameworks evolve.
Personalized Small-Batch Production
From biological data to a fresh, labeled batch.
-
Nutritional Profile Generated & Baby-Specific Barcode
The AI engine produces a precise nutritional blueprint based on the infant's biological data, and a baby-specific barcode/traceability ID is assigned.
-
Micro-Precision Ingredients
Ingredients are selected and measured with pharmaceutical-level accuracy.
-
Clean-Room Sterile Blending
Formulation is blended in controlled clean-room environments under sterile conditions, ensuring safety and consistency.
-
Quality Testing
Each batch undergoes comprehensive testing before release.
-
Fresh Packaging & Shipment
Finished formula is packaged and shipped directly to the family.
Scalable by Design
Modular growth from pilot to global capacity.
The Auralis manufacturing platform is designed to grow modularly. New production units can be added without redesigning the core system, enabling efficient expansion from pilot-scale to regional and global production capacity.
Modular Units
Production units can be added without redesigning the core system.
Automated Processes
Automated steps reduce variability and increase consistent throughput.
AI-Driven Forecasting
Predictive demand and biological forecasting drive production planning.
Cloud-Based Monitoring
Real-time monitoring across facilities ensures quality at every stage.
Intellectual Property & Competitive Edge
A defensible, end-to-end manufacturing IP.
Auralis's manufacturing process is a core component of its intellectual property portfolio. The end-to-end system — from AI-driven formulation to small-batch precision blending — is proprietary, defensible, and designed for scalable commercial deployment.
Proprietary Algorithms
AI-driven formulation logic translating biology into nutritional blueprints.
Custom Workflows
End-to-end workflows engineered for personalized infant formula production.
Small-Batch Architecture
A modular small-batch system that scales without re-engineering the core.
Microbiome + Infant Host Genetic DNA Integration
A platform integrating microbiome and genetic data into a personalized formula at industrial scale.